McKinsey Health Institute report calls for chang

Jesse Poganik, Codirector, Biomarkers of Aging C

Debut targets US and Asia expansion, leveraging

Minovia Therapeutics Ltd.

Omada Health released research demonstrating that

Portfolia has launched Women’s Health Fund IV,

L-Nutra’s latest iteration of its Fasting Mimi

Preventive health provider teams up with Alamar

Amylyx Pharmaceuticals has announced that it will

UCSF researchers demonstrate that the pro-aging

Longevity biotech presents data demonstrating th

Cerecin, a global biotech firm focused on neurome

Human Longevity, Inc.

HCW Biologics Inc., a U.S.

Serina Therapeutics announced that feedback from

Jupiter Neurosciences has launched a new Nugevia

Nanoscope Therapeutics presented three-year follo

ARDD presentation addresses the need for consens

A form of interval walking training, known as &#82

Cellular reprogramming research collab with Retr

Lighthouse Pharmaceuticals received a $49.

Lighthouse Pharma lands major grant funding to a

Japanese XPRIZE semifinalist draws on Nobel-winn

Protagenic Therapeutics has completed first-dose

Milken Institute calls for greater investment in

DiamiR Biosciences and Aptorum Group announced th

Life Time has launched a new sleep-support produc

Clinical trials, biomarker standardization and s

Patientory has made its AI-Enterprise Analytics D

Anavex announced the publication of a peer-review

Superpower launched a $199-per-year membership ai

Buck Institute study finds genetic trade-offs th

dōTERRA has launched its “Wellness Made Simple

Hangzhou Qihan Biotech has received FDA clearance

Edinburgh study finds feline cognitive decline m

Ethos and Lifeforce join forces to combine life

Celularity has completed a major balance sheet re

Genflow Biosciences reported progress in its proo

Form Bio, an AI-powered genetic medicine and geno

BioAge Labs has dosed the first participant in th

Healthy Longevity Medicine Society’s Arthur Cl

China’s only XPRIZE Healthspan Top 40 team is

Isaac Health has secured $10.

ReviveHealth, Inc.

Immunis, Inc.

MetaVia CEO says tolerability is key to the long

Evernow has partnered with Ōura, maker of the sm

Neuronascent has published the Phase 1a clinical

Seragon Biosciences has launched Enlivien®, a no

Seraphina Therapeutics has achieved a notable ran